To assess whether targeting MDK would augment the anti-tumor activity of IFN-γ in ovarian cancer, we treated the SKOV3 cells with a potent MDK inhibitor, iMDK, and then evaluated the effect of MDK inhibition on the tumoricidal activity of IFN-γ. The gene discussed is IFNG; the disease is ovarian carcinoma.